Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000259157 | SCV000152358 | likely benign | not specified | 2015-12-02 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000259157 | SCV000227683 | benign | not specified | 2014-11-20 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000828432 | SCV000970120 | likely benign | not provided | 2020-10-24 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001088136 | SCV001012185 | likely benign | Autosomal recessive limb-girdle muscular dystrophy type 2K; Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1; Walker-Warburg congenital muscular dystrophy | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000828432 | SCV001145184 | likely benign | not provided | 2018-09-14 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000828432 | SCV005225939 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV004529977 | SCV004744760 | likely benign | POMT1-related disorder | 2021-01-25 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |